Extracellular vesicle-associated transcriptomic and proteomic biomarkers show in-vitro potential for vandetanib treatment monitoring in anaplastic thyroid cancer

ABSTRACT: Extracellular vesicle-associated transcriptomic and proteomic biomarkers show in-vitro potential for vandetanib treatment monitoring in anaplastic thyroid cancer

PROVIDER: PRJEB88458 | ENA |

REPOSITORIES: ENA